Saturday 17 October 2026
Export ADTX’s income statement to Excel — free account
Aditxt, Inc.
ADTX Healthcare Biotechnology
Aditxt, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3,200.00, down 97.6% from fiscal 2024. In the quarter to March 2026, revenue grew 1,120.0%, EPS grew 99.6% and free cash flow grew 60.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.00
0.00
NaN
Follow ADTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Altman Z-Score |
(22.29) | — | — | 56,781,192.35 | 9,245,521,862.05 | — | — | — | — |
P/S ratio |
81.45 | 0.00 | 0.00 | 766,584,229.03 | 0.00 | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(52.38) | (27.20) | (15.47) | (43.15) | (26.15) | — | — | — | — |
Beneish M-Score |
— | — | — | 2.23 | — | — | — | — | — |
P/Operating CF |
(0.03) | 0.00 | 0.00 | (106,511,859.32) | (11,494,316,640.52) | — | — | — | — |
P/B ratio |
0.06 | 0.00 | 0.00 | 137,479,533.38 | 9,812,529,937.34 | — | — | — | — |
Price to Tangible BV |
0.06 | 0.00 | 0.00 | 140,364,303.85 | 10,023,217,560.91 | — | — | — | — |
EV/Sales |
(525.68) | 3.61 | 1.89 | 766,584,227.47 | 0.00 | — | — | — | — |
EV/EBITDA |
0.09 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
0.06 | (0.03) | (0.06) | (31,964,973.79) | (4,484,197,699.96) | — | — | — | — |
EV/FCF |
0.06 | (0.03) | (0.06) | (31,449,384.78) | (4,288,650,881.97) | — | — | — | — |
Quick Ratio |
0.26 | 0.08 | 0.23 | 0.90 | 2.21 | 8.56 | 0.00 | 0.07 | 0.42 |
Current Ratio |
0.31 | 0.09 | 0.27 | 1.30 | 2.61 | 8.99 | 0.00 | 0.07 | 0.42 |
Net Debt/EBITDA |
0.18 | 0.03 | 0.00 | 0.12 | 0.20 | 1.23 | 0.00 | (0.01) | 0.12 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 141.40% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.11) | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.02 | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.60 | 0.42 | 0.59 | 0.81 | 0.48 | 0.79 | 0.08 | 0.07 | 0.00 |
Capex/Depreciation |
(0.01) | 0.00 | (0.01) | (0.18) | (0.44) | (0.54) | — | — | — |
Interest Coverage |
(28.73) | (6.65) | (6.21) | (33.84) | (449.95) | (878.44) | (3,089.89) | (140.59) | — |
| (1,708.68%) | (470.92%) | (307.73%) | (359.88%) | (436.66%) | (224.26%) | 265.57% | 712.66% | 26.68% | |
| (177.15%) | (105.19%) | (118.24%) | (202.11%) | (310.94%) | (138.41%) | (4,872.66%) | (9,834.40%) | (302.77%) | |
ROIC |
(1,619.88%) | (6,739.48%) | (102.13%) | (653.28%) | (1,135.24%) | (1,085.79%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
573.29% | 203.19% | 191.47% | (809.86%) | (572.86%) | (86.27%) | 196.11% | 370.22% | 610.32% |
Average Days of Receivables |
0.00 | 3,138.46 | 3,311.14 | 206.40 | 312.16 | — | — | — | — |
Research and Development Expense of Revenue |
99,815.63% | 8,123.96% | 1,096.45% | 778.42% | 4,802.48% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
511,778.13% | 12,301.57% | 2,925.67% | 1,910.14% | 21,351.81% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
15,103.13% | 5,034.10% | 217.30% | 335.38% | 4,419.71% | 0.00% | 0.00% | — | — |
Graham Net Nets |
(34.62) | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Earnings Yield |
(12,594.08%) | (145,098.94%) | (56.19%) | 0.00% | 0.00% | — | — | — | — |
Free Cash Flow Yield |
(10,182.61%) | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — |
Revenue per Share |
2.29 | 0.00 | 0.00 | 20.12 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(18,348.86) | 0.00 | 0.00 | (482.59) | (58.35) | (1.05) | (0.12) | (148.58) | 0.00 |
Capex per Share |
(9.79) | 0.00 | 0.00 | (7.91) | (2.66) | (0.02) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(18,358.64) | 0.00 | 0.00 | (490.50) | (61.01) | (1.07) | (0.12) | (148.58) | 0.00 |
Cash per Share |
2,284.71 | 0.00 | 0.00 | 59.67 | 20.62 | 1.52 | 0.00 | 44.50 | 0.24 |
Shareholders Equity per Share |
2,824.07 | 0.00 | 0.00 | 112.20 | 26.67 | 1.60 | (0.74) | (591.04) | (0.58) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2,824.07 | 0.00 | 0.00 | 112.20 | 26.67 | 1.60 | (0.74) | (591.04) | (0.58) |
Free Cash Flow |
(25.70) | (16.76) | (19.22) | (22.76) | (23.29) | (7.39) | (0.46) | (0.39) | — |
Working Capital |
(8.40) | (21.41) | (18.98) | 1.10 | 5.81 | 9.81 | (2.97) | (1.54) | (0.03) |
Capital Expenditures |
(0.01) | — | (0.01) | (0.37) | (1.02) | (0.17) | — | — | — |
Net Current Asset Value |
(8.74) | (29.05) | (21.62) | (0.79) | 2.93 | 8.95 | (2.97) | (1.54) | (0.06) |
EV/EBIT |
0.08 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Capex to Sales |
4.28 | 0.00 | 0.02 | 0.39 | 9.67 | 0.00 | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
2.00 | 2.45 | 1.44 | 0.89 | 1.02 | 0.40 | — | — | — |
Cash ROIC |
(359.35%) | (871.03%) | (119.04%) | (285.38%) | (129.03%) | (34.36%) | 16.31% | 30.72% | 0.00% |
Accounts Receivable Turnover |
0.00 | 0.04 | 0.20 | 3.02 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.06 | 0.14 | 0.43 | 0.09 | 0.02 | 0.00 | 0.00 | — |
Inventory Turnover |
0.34 | 1.66 | 0.89 | 1.06 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
968,307.24 | 7,685.18 | 4,126.02 | 932.25 | 7,372.53 | 4,954.16 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
730.00 | 6.51 | 359.55 | 452.25 | 2,314.94 | 0.00 | — | — | — |
Average Receivables |
— | 3.50 | 3.19 | 0.31 | — | — | — | — | — |
Average Payables |
10.45 | 10.88 | 5.26 | 1.77 | 0.91 | 1.04 | 1.45 | 1.45 | — |
Average Inventory |
0.01 | 0.38 | 0.85 | 0.72 | — | — | — | — | — |
Average Assets |
24.33 | 38.36 | 27.66 | 13.70 | 14.88 | 6.61 | 0.12 | 0.06 | 0.07 |
Average Common Equity |
2.52 | 8.57 | 10.63 | 7.69 | 10.60 | 4.08 | (2.19) | (0.80) | (0.80) |
Columns are period end dates · fundamentals updated 2 Oct 2026